Skip to main content
Board of Directors
Innovation engine overview
Extracting microbial biodiversity
Screening for new activity
Active compound characterization
Technology platform overview
DEINOVE is pioneering the exploration of “microbial dark matter”
By revealing the metabolic potential of rare bacteria or still classified as uncultivable, the company tackles a global health and economic challenge:
DEINOVE, ESPCI Paris and INRAE awarded grant following the call for proposals of the French “Antibiotic resistance” Priority Research Program
The Microflu4AMR project, based on microfluidic technology and the exploitation of soil microbial...
DEINOVE presents its financial results and the advancement of its programs for 2020
Phase II of the antibiotic candidate DNV3837 ongoing – end of the first part of the trial (DSMB)...
More press releases